This inventor holds 4 USPTO granted patents and 5 published patent applications and 3 EPO patents. Top assignees: Cipherome, Inc., Seoul National University, Other. Active years: 2014-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2014-2021
Title: Ju Han Kim: Innovator in Personalized Medicine
Introduction
Ju Han Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of personalized medicine, particularly in the development of methods for selecting anticancer agents tailored to individual patients. With a total of 4 patents, his work focuses on enhancing the efficacy and safety of cancer treatments.
Latest Patents
One of his latest patents is a method for selecting an anticancer agent based on protein damage information of an individual to prevent anticancer agent side effects. This invention relates to a method and a system that utilizes individual genome sequencing to predict the side effects or risks associated with specific anticancer agents. By performing sequence analysis of the exon part of a gene that codes for various proteins involved in pharmacokinetics or pharmacodynamics, this method offers a highly reliable and widely applicable technique for personalized treatment.
Another notable patent is a method for personalized selection of a drug for a subject. This invention also employs individual genome sequences to customize drug selection based on individual protein information. The system can predict potential side effects or dangers of a certain drug by analyzing the exon region of genes encoding proteins involved in drug metabolism, ensuring high reliability and universal applicability.
Career Highlights
Throughout his career, Ju Han Kim has worked with various organizations, including Cipherome, Inc. His innovative approaches have positioned him as a key figure in the realm of personalized medicine, where his inventions aim to improve patient outcomes and minimize adverse effects of treatments.
Collaborations
Ju Han Kim has collaborated with notable professionals in his field, including Byung Hoon Lee and Su Yeon Baik. These partnerships have further enriched his research and development efforts, contributing to advancements in personalized healthcare solutions.
Conclusion
Ju Han Kim's work exemplifies the potential of personalized medicine in transforming cancer treatment. His innovative patents and collaborative efforts continue to pave the way for safer and more effective therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile